First Letting Secured at Sidney Sussex Building, Chesterford Research Park
Three-storey, multi-occupancy R&D building welcomes Camena Bioscience
Cambridge, UK, 28th April 2026: Chesterford Research Park has secured the first letting at the newly completed Sidney Sussex Building, with Suite 5 (2,910 sq ft) taken by existing occupier Camena Bioscience (Camena).
The move sees Camena relocate from the Park’s Science Village to consolidate its team within a single, purpose-built, fully fitted laboratory and office suite, enabling the company to benefit…
Silverstone, UK, 30 April 2026: Lab Thread Ltd, a UK-based life science software company, today announced the worldwide commercial release of its Unified Lab Software Platform. By linking functional modules including molecular biology tools, electronic notebook (ELN) records and laboratory information management (LIMS) functionality, Lab Thread creates a simple, secure digital thread – bringing together scientific teams, data and entire laboratory workflows to accelerate biological research and advance scientific discovery.
Initially launched into beta in December 20251, the Lab Thread…
LONDON, UK and UTRECHT, the Netherlands – April 30, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Laigo Bio (“Laigo”) and is pleased to announce the placement of Dr. Richard C.A. Sainson as its new Chief Scientific Officer (CSO).Laigo Bio is an early-stage biotech company pioneering the use of E3 ligase induced internalization and selective degradation of membrane-bound targets involved in autoimmune and inflammatory diseases. Its proprietary…
Amsbio has expanded its range of iPSC Differentiation Kits that provide fast and flexible generation of specific cell types without sacrificing cell purity.
New to market - Quick-Glia™ product line consist of human induced pluripotent stem cell derived glial cells designed for rapid, reliable, and reproducible research in neurobiology, drug discovery, and neurodegeneration. Offering a reproducible, and scalable solution, these kits enable the conversion of iPSCs into functional neurons in just 1-2 weeks. Designed for ease of use, they provide a streamlined workflow…
Supporting our network's growth remains at the heart of what we do. Explore our upcoming learning opportunities and discover how you can continue to develop your skills, connect with others, and stay ahead in the sector.________________________________________________
One Nucleus Training
6-7 May 2026 | Online Introduction to Managing Life Science Projects, Register Here...
This one-day face-to-face training equips new or transitioning project managers and technical staff in life sciences with practical project management skills. It covers the end-to-end project process, key tools,…
Deloitte is calling on the most innovative and rapidly growing technology scale-ups across Cambridgeshire and the East of England to apply for the firm’s prestigious UK Technology Fast 50. Applications for this year's programme are officially open from today.
The annual ranking celebrates the fastest-growing tech companies across the UK, based on average revenue growth over a three-year period. Last year’s Technology Fast 50 winners had a collective average three-year growth rate of 1,905% and generated total revenues of £2.41 billion in 2024/25.
Cambridge-based decarbonisation company…
LONDON, UK and COPENHAGEN, Denmark – April 22, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Oral Care AB and is pleased to announce the placement of Lucas Kromann as Chief Executive Officer (CEO) Denmark.Oral Care is a leading dental care service provider offering both clinic-based and mobile dental services across Sweden, Norway, and the Netherlands. Following its acquisition by the Nordic private equity group Axcel in 2022, Oral Care is now…
As a long-standing partner of One Nucleus, Digital Science are committed to providing the Biotech and Pharma community with the tools needed to navigate an increasingly complex data landscape. We are excited to introduce Compass, our newest dedicated application designed to transform how your Medical Affairs and Publication Planning teams measure impact.
For our partners in both emerging biotech and established pharma, the challenge is often the same: navigating "the black hole" of publication tracking. Compass solves this by unifying Dimensions citation data and Altmetric attention…
LONDON, UK – April 16, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search for Babraham Research Campus Ltd (BRCL) and is pleased to announce the placement of Dr. Rich Ferrie as Chief Executive Officer (CEO). Babraham Research Campus is one of the UK’s leading places to support early-stage bioscience enterprise. It is distinct in its co-location of over 60 bioscience companies alongside the Babraham Institute – creating an environment where world class research and business…
Some of the UK’s most ambitious early-stage life science companies are choosing Victoria House as their London base, adding fresh momentum to one of the capital’s most exciting life science communities.
Developed by Oxford Properties and Pioneer Group, the Bloomsbury Square building has attracted 24 innovative organisations since it launched last year, drawn by a rare and unique combination of high-quality incubator labs, flexible workspace, and a genuinely collaborative community.
Among the latest arrivals to Victoria House is Draig Therapeutics, a clinical-stage biopharmaceutical company…